Selective serotonin re-uptake inhibitors: the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Chichester u.a.
Wiley
1991
|
| Schriftenreihe: | Perspectives in psychiatry
1 |
| Schlagworte: | |
| Beschreibung: | 168 S. Ill., graph. Darst. |
| ISBN: | 0471928909 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV008955742 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 940206s1991 ad|| |||| 00||| eng d | ||
| 020 | |a 0471928909 |9 0-471-92890-9 | ||
| 035 | |a (OCoLC)22705819 | ||
| 035 | |a (DE-599)BVBBV008955742 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-29 |a DE-19 |a DE-578 | ||
| 050 | 0 | |a RC483 | |
| 050 | 0 | |a RM332 | |
| 080 | |a 616.89-008 | ||
| 082 | 0 | |a 616.85/27061 |2 20 | |
| 084 | |a XI 5800 |0 (DE-625)153018:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Selective serotonin re-uptake inhibitors |b the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline |c J. P. Feighner ... |
| 264 | 1 | |a Chichester u.a. |b Wiley |c 1991 | |
| 300 | |a 168 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Perspectives in psychiatry |v 1 | |
| 650 | 4 | |a Humans - Mental disorders - Drug therapy | |
| 650 | 4 | |a Mental disorders - Drug therapy | |
| 650 | 7 | |a Antagonisten |2 gtt | |
| 650 | 7 | |a Antidepressiva |2 gtt | |
| 650 | 4 | |a Antidépresseurs | |
| 650 | 7 | |a Serotonine |2 gtt | |
| 650 | 4 | |a Systèmes sérotoninergiques | |
| 650 | 4 | |a Sérotonine - Agonistes | |
| 650 | 4 | |a Antidepressants | |
| 650 | 4 | |a Mental Disorders |x drug therapy | |
| 650 | 4 | |a Serotonin Antagonists |x therapeutic use | |
| 650 | 4 | |a Serotonin uptake inhibitors | |
| 650 | 4 | |a Serotoninergic mechanisms | |
| 700 | 1 | |a Feighner, John P. |e Sonstige |4 oth | |
| 830 | 0 | |a Perspectives in psychiatry |v 1 |w (DE-604)BV005540222 |9 1 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-005910350 | ||
Datensatz im Suchindex
| _version_ | 1804123289749028864 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV008955742 |
| callnumber-first | R - Medicine |
| callnumber-label | RC483 |
| callnumber-raw | RC483 RM332 |
| callnumber-search | RC483 RM332 |
| callnumber-sort | RC 3483 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XI 5800 |
| ctrlnum | (OCoLC)22705819 (DE-599)BVBBV008955742 |
| dewey-full | 616.85/27061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.85/27061 |
| dewey-search | 616.85/27061 |
| dewey-sort | 3616.85 527061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01631nam a2200493 cb4500</leader><controlfield tag="001">BV008955742</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">940206s1991 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0471928909</subfield><subfield code="9">0-471-92890-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)22705819</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008955742</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC483</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM332</subfield></datafield><datafield tag="080" ind1=" " ind2=" "><subfield code="a">616.89-008</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.85/27061</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5800</subfield><subfield code="0">(DE-625)153018:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Selective serotonin re-uptake inhibitors</subfield><subfield code="b">the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline</subfield><subfield code="c">J. P. Feighner ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chichester u.a.</subfield><subfield code="b">Wiley</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">168 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Perspectives in psychiatry</subfield><subfield code="v">1</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Humans - Mental disorders - Drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental disorders - Drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antagonisten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antidepressiva</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antidépresseurs</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Serotonine</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Systèmes sérotoninergiques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sérotonine - Agonistes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antidepressants</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental Disorders</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Serotonin Antagonists</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Serotonin uptake inhibitors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Serotoninergic mechanisms</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Feighner, John P.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Perspectives in psychiatry</subfield><subfield code="v">1</subfield><subfield code="w">(DE-604)BV005540222</subfield><subfield code="9">1</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005910350</subfield></datafield></record></collection> |
| id | DE-604.BV008955742 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:27:25Z |
| institution | BVB |
| isbn | 0471928909 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005910350 |
| oclc_num | 22705819 |
| open_access_boolean | |
| owner | DE-29 DE-19 DE-BY-UBM DE-578 |
| owner_facet | DE-29 DE-19 DE-BY-UBM DE-578 |
| physical | 168 S. Ill., graph. Darst. |
| publishDate | 1991 |
| publishDateSearch | 1991 |
| publishDateSort | 1991 |
| publisher | Wiley |
| record_format | marc |
| series | Perspectives in psychiatry |
| series2 | Perspectives in psychiatry |
| spelling | Selective serotonin re-uptake inhibitors the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline J. P. Feighner ... Chichester u.a. Wiley 1991 168 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Perspectives in psychiatry 1 Humans - Mental disorders - Drug therapy Mental disorders - Drug therapy Antagonisten gtt Antidepressiva gtt Antidépresseurs Serotonine gtt Systèmes sérotoninergiques Sérotonine - Agonistes Antidepressants Mental Disorders drug therapy Serotonin Antagonists therapeutic use Serotonin uptake inhibitors Serotoninergic mechanisms Feighner, John P. Sonstige oth Perspectives in psychiatry 1 (DE-604)BV005540222 1 |
| spellingShingle | Selective serotonin re-uptake inhibitors the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline Perspectives in psychiatry Humans - Mental disorders - Drug therapy Mental disorders - Drug therapy Antagonisten gtt Antidepressiva gtt Antidépresseurs Serotonine gtt Systèmes sérotoninergiques Sérotonine - Agonistes Antidepressants Mental Disorders drug therapy Serotonin Antagonists therapeutic use Serotonin uptake inhibitors Serotoninergic mechanisms |
| title | Selective serotonin re-uptake inhibitors the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline |
| title_auth | Selective serotonin re-uptake inhibitors the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline |
| title_exact_search | Selective serotonin re-uptake inhibitors the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline |
| title_full | Selective serotonin re-uptake inhibitors the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline J. P. Feighner ... |
| title_fullStr | Selective serotonin re-uptake inhibitors the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline J. P. Feighner ... |
| title_full_unstemmed | Selective serotonin re-uptake inhibitors the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline J. P. Feighner ... |
| title_short | Selective serotonin re-uptake inhibitors |
| title_sort | selective serotonin re uptake inhibitors the clinical use of citalopram fluoxetine fluvoxamine paroxetine and sertraline |
| title_sub | the clinical use of citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline |
| topic | Humans - Mental disorders - Drug therapy Mental disorders - Drug therapy Antagonisten gtt Antidepressiva gtt Antidépresseurs Serotonine gtt Systèmes sérotoninergiques Sérotonine - Agonistes Antidepressants Mental Disorders drug therapy Serotonin Antagonists therapeutic use Serotonin uptake inhibitors Serotoninergic mechanisms |
| topic_facet | Humans - Mental disorders - Drug therapy Mental disorders - Drug therapy Antagonisten Antidepressiva Antidépresseurs Serotonine Systèmes sérotoninergiques Sérotonine - Agonistes Antidepressants Mental Disorders drug therapy Serotonin Antagonists therapeutic use Serotonin uptake inhibitors Serotoninergic mechanisms |
| volume_link | (DE-604)BV005540222 |
| work_keys_str_mv | AT feighnerjohnp selectiveserotoninreuptakeinhibitorstheclinicaluseofcitalopramfluoxetinefluvoxamineparoxetineandsertraline |